Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis

Matching-Adjusted Indirect Comparison of Oral Paclitaxel (Liporaxel®) Versus Weekly Intravenous Paclitaxel in Advanced Gastric Cancer.
Hyung-Don Kim, Sungju Kim, Eileen J Shin +5
Journal of gastric cancer1 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
Skeletal Muscle Index, Tumor and Systemic Immunity, and Survival in Advanced Pancreatic Ductal Adenocarcinoma
Yue Ma, Ru Jia, Mengjiao Fan +12
Cancer medicine1 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells
K. A. Hawthorne, J. R. Eng, M. Tsuda +12
bioRxiv28 Sep 2026PreprintAll rights reservedFull textOncologybioRxiv
KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma
y. chen, C. Haffner, B. Chellakkan Selvanesan +24
bioRxiv5 Oct 2026PreprintAll rights reservedFull textOncologybioRxiv
The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5 Splice Site Dependent Splicing Regulation
L. Wan, M. Wang, Y. Ishigami +5
bioRxiv6 Oct 2026PreprintCC BY-NC-NDFull textOncologybioRxiv

Cite

BibTeX

@misc{jaareh2026crosssource,
  title = {{Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis}},
  author = {H. A. Jaareh and F. Habash and S. Mustafa and E. H. S. Saleh},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.13.26362944},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.13.26362944v1},
}

RIS

TY  - UNPB
TI  - Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis
AU  - H. A. Jaareh
AU  - F. Habash
AU  - S. Mustafa
AU  - E. H. S. Saleh
PY  - 2026
DA  - 2026/09/13
PB  - medRxiv
DO  - 10.64898/2026.09.13.26362944
UR  - https://www.medrxiv.org/content/10.64898/2026.09.13.26362944v1
ER  -

Related

Cite